01 8TETRAPHASE PHARMS
01 28796245
02 28906887
03 210961190
04 211578044
01 4Y
02 4Blank
01 2Y
02 6Blank
01 22029-08-07
02 22030-12-28
03 42037-10-19
Patent Expiration Date : 2029-08-07
US Patent Number : 8796245
Drug Substance Claim :
Drug Product Claim :
Application Number : 211109
Patent Use Code : U-2380
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-07
Patent Expiration Date : 2029-08-07
US Patent Number : 8796245
Drug Substance Claim :
Drug Product Claim :
Application Number : 211109
Patent Use Code : U-2380
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-08-07
Patent Expiration Date : 2037-10-19
US Patent Number : 11578044
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 211109
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-19
Patent Expiration Date : 2030-12-28
US Patent Number : 8906887
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211109
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-12-28
Patent Expiration Date : 2037-10-19
US Patent Number : 10961190
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 211109
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-19
Patent Expiration Date : 2037-10-19
US Patent Number : 10961190
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 211109
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-19
Patent Expiration Date : 2030-12-28
US Patent Number : 8906887
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211109
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-12-28
Patent Expiration Date : 2037-10-19
US Patent Number : 11578044
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 211109
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-19
